glp 1 agonist metformin Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: A nationwide cohort study Semaglutide dominates GLP-1 receptor agonist

Description

GIP may have anti-emetic properties) or dulaglutide (lower nausea rate than semaglutide in head-to-head trials) Slower titration schedule: Liraglutide (daily dosing allows finer dose adjustments) or compounded semaglutide (allows custom titration steps) The decision tree assumes you are working with a prescribing provider

The decision to initiate GLP-1 therapy should always be based on primary indicationstype 2 diabetes management or weight management in obesitywith lipid improvements considered a valuable secondary benefit

Elkind-Hirsch K, Marrioneaux O, Bhushan M, et al

2024;7:e2413172

A newer version of phentermine (combining phentermine with topiramate in one pill) was approved for chronic weight management in adults and kids down to age 12 in 2012 and marketed as Qsymia